Ryan Nipp to Carcinoma, Hepatocellular
This is a "connection" page, showing publications Ryan Nipp has written about Carcinoma, Hepatocellular.
Connection Strength
0.161
-
Ramucirumab in the second-line for patients with hepatocellular carcinoma and elevated alpha-fetoprotein: patient-reported outcomes across two randomised clinical trials. ESMO Open. 2020 08; 5(4).
Score: 0.161